Updated September 9, 2019 This content is archived.
A $7 million UB-led telemedicine study that can provide lifesaving treatment of Hepatitis C to those recovering from drug addiction has shown such promise that it has been expanded across New York State. “I think you'd want to do both at the same time because the treatment for Hep C in many ways helps substance users get control of their lives,” said Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition. “Patients are very happy when they find out that they no longer have to deal with Hep C. It gives them a real benefit on the road to recovery.”